Vancouver, British Columbia--(Newsfile Corp. - June 30, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"),…
DALLAS, June 30, 2025 /PRNewswire/ -- Axxess, the leading global technology platform for healthcare at home, has partnered with Zing…
Two graduate students receive grants supporting their research into the gut microbiome and probiotics in a program championing the next…
In the study of rare diseases and precision medicine, understanding gene expression in the spatial context of tissues is essential. High-throughput…
New research reveals that subtle response-time biomarkers—captured in minutes via digital assessments—can flag Alzheimer's and dementia risk far earlier than…
North Bergen, New Jersey--(Newsfile Corp. - June 26, 2025) - Apollo Biowellness, Inc. formerly known as Resonate Blends, Inc. (OTC…
Hybrid, decentralized trial of bezisterim in early Parkinson’s Disease prioritizes patient access and participationCARSON CITY, Nev., June 26, 2025 (GLOBE…
U.S. commercial rollout of novel diagnostic platform to begin second half 2025 Underserved CNS cancer diagnostic U.S. market opportunity estimated…
Updated cash guidance provides runway into at least mid-2026 MDNA11 Phase 1/2 clinical trial on track for data readouts in…
TORONTO, June 26, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a…